Viewing Study NCT05036135


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-29 @ 5:56 PM
Study NCT ID: NCT05036135
Status: TERMINATED
Last Update Posted: 2024-08-23
First Post: 2021-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE2 View
None PHASE3 View
Observational Models:
Time Perspective List:
Who Masked List: